CTEC logo

ConvaTec Group PLC Stock Price

LSE:CTEC Community·UK£4.8b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author

CTEC Share Price Performance

UK£2.39
0.13 (5.66%)
21.4% undervalued intrinsic discount
UK£3.04
Fair Value
UK£2.39
0.13 (5.66%)
22.7% undervalued intrinsic discount
UK£3.09
Fair Value
Price UK£2.39
AnalystConsensusTarget UK£3.09

CTEC Community Narratives

AnalystConsensusTarget·Updated
Fair Value UK£3.04 21.5% undervalued intrinsic discount

Global Demographic Shifts And Emerging Markets Will Create Enduring Opportunity

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative

Recent CTEC News & Updates

Returns On Capital Are Showing Encouraging Signs At ConvaTec Group (LON:CTEC)

Sep 10
Returns On Capital Are Showing Encouraging Signs At ConvaTec Group (LON:CTEC)

ConvaTec Group PLC Key Details

US$2.4b

Revenue

US$1.0b

Cost of Revenue

US$1.3b

Gross Profit

US$1.1b

Other Expenses

US$216.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 25, 2026
Earnings per share (EPS)
0.11
Gross Margin
56.09%
Net Profit Margin
9.20%
Debt/Equity Ratio
69.6%

ConvaTec Group PLC Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with solid track record.

3 Risks
4 Rewards

About CTEC

Founded
1978
Employees
10000
CEO
Jonathan Mason
WebsiteView website
www.convatecgroup.com

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson’s disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.K. Market Performance

  • 7 Days: 2.0%
  • 3 Months: 7.1%
  • 1 Year: 13.2%
  • Year to Date: 14.5%
The market has climbed 2.0% in the last 7 days, lead by the Healthcare sector with a gain of 10%. The market is up 13% over the last 12 months. As for the next few years, earnings are expected to grow by 14% per annum. Market details ›